HemOnc Today New York

The latest news from the annual meeting, including video perspective from faculty members and attendees.


Meeting News Coverage

Emerging technologies allow patients, computers to help diagnose melanoma

April 1, 2013
NEW YORK — Emerging technologies during the next 5 to 10 years will assist physicians in surveillance of melanoma through advances in imaging…
Meeting News CoveragePerspective

Nab-paclitaxel shows promise in treatment of metastatic melanoma

March 28, 2013
NEW YORK — Nanoparticle albumin-bound paclitaxel is an active agent in the treatment of malignant melanoma, but its role in relationship to…
Meeting News Coverage

Maintenance IL-2, GM-CSF may improve response in metastatic melanoma

HemOnc Today, April 10, 2013
NEW YORK — Maintenance therapy with interleukin-2 and sargramostim may help extend positive outcomes in patients with metastatic melanoma who…
Meeting News Coverage

Tumor-infiltrating lymphocytes fail to predict aggressive tumor biology

HemOnc Today, April 10, 2013
NEW YORK — Histopathological detection of tumor-infiltrating lymphocytes has not shown to be an accurate indicator of aggressive tumor biology…
Meeting News Coverage

HD IL-2 should be considered for patients with melanoma brain metastases

HemOnc Today, April 25, 2013
NEW YORK — Patients with melanoma who have brain metastases should not be considered ineligible for treatment with high-dose interleukin-2…
Meeting News CoveragePerspectivePublication Exclusive

Biochemotherapy offers potential alternative to interferon for high-risk melanoma

HemOnc Today, April 25, 2013
NEW YORK — Biochemotherapy may be a viable alternative to interferon in adjuvant therapy for high-risk melanoma patients, according to a…
Meeting News CoveragePerspective

IL-12 plasmid electroporation appears effective in metastatic melanoma

March 26, 2013
NEW YORK — Electroporation with interleukin-12 plasmid was associated with positive durable response rates and a tolerable adverse effect…
Meeting News Coverage

‘Ugly DUC-ling’ criteria may increase early detection of melanoma

HemOnc Today, April 10, 2013
NEW YORK — Expanded diagnostic criteria that include identification of different, uneven or changing lesions can enhance sensitivity for early…
Meeting News CoverageVideo

Highlights from the HemOnc Today Melanoma symposium

March 24, 2013
NEW YORK — Sanjiv S. Agarwala, MD, highlights the topics covered at the HemOnc Today Melanoma and Cutaneous Malignancies symposium including…
Meeting News CoverageVideo

Adoptive T-Cell transfer

March 23, 2013
Patrick Hwu, MD, discussed recent results of an ongoing adoptive cell therapy trial, MDACC TIL ACT clinical trial, at the HemOnc Today Melanoma and…